Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC) Conference Paper uri icon

authors

  • Yen, Chia-Jui
  • Benjamin, Markman
  • Chao, Yee
  • Andrew, Hill
  • Kang, Jinyu
  • Wang, Lai
  • Li, Kang
  • Qi, Qinzhou
  • Wu, Zhong
  • Gan, Hui

publication date

  • June 1, 2017